Cynthia J Guidos

13PUBLICATIONS
57CO-AUTHORS
Tissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 20, 2026
TGFb signaling instructs a conserved fibrosis-associated cell state marked by LRRC15.

|Nov 24, 2025
Sequential Lymphotoxin Beta Receptor and Retinoic Acid Receptor signals regulate cDC2 fates.

Albert A Nguyen, Logan Fisher, Jennifer S Y Ahn

|Nov 21, 2025
Sequential lymphotoxin-β receptor and retinoic acid receptor signals regulate cDC2 fate.

Albert A Nguyen, Logan Fisher, Jennifer S Y Ahn

|Jun 12, 2025
HEB collaborates with TCR signaling to upregulate Id3 and enable γδT17 cell maturation in the fetal thymus.

Johanna S Selvaratnam, Juliana Dutra Barbosa da Rocha, Vinothkumar Rajan

|Sep 05, 2023
Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.

Dzana Dervovic, Ahmad A Malik, Edward L Y Chen

|May 31, 2023
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.

Dzana Dervovic, Ahmad A Malik, Edward L Y Chen

Pageof 3